I agree that this site is using cookies. You can find further informations here.
X
U. Herrlinger
139  results:
Search for persons X
?
1

P11.21.A LONG-TERM SURVIVAL WITH IDH WILDTYPE GLIOBLASTOMA:..:

Weller, M ; Felsberg, J ; Gramatzki, D...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii77-ii77 , 2023
Link: https://doi.org/10.1093/..
 
?
2

PO-1088 Impact of nationality on the quality of early side ..:

Koeksal, M. ; Streppel, R. ; Schmeel, C....
Radiotherapy and Oncology.  182 (2023)  - p. S871 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Patterns, predictors and prognostic relevance of high-grade..:

Weller, J. ; Schäfer, N. ; Schaub, C....
Journal of Neuro-Oncology.  161 (2023)  1 - p. 147-153 , 2023
Link: https://doi.org/10.1007/..
 
?
4

P11.65.B TEMPORAL MUSCLE THICKNESS AS A PROGNOSTIC MARKER I..:

Lazaridis, L ; Moenninghoff, C ; Schmidt, T...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii89-ii90 , 2023
Link: https://doi.org/10.1093/..
 
?
5

PL01.4.A LATE BREAKING ABSTRACT: A LONG PEPTIDE VACCINE TAR..:

Grassl, N ; Poschke, I ; Lindner, K...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii1-ii1 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Gliosarcoma with extensive extracranial metastatic spread a..:

Friker, L.L. ; Tzaridis, T. ; Enkirch, S.J....
Pathology - Research and Practice.  244 (2023)  - p. 154399 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P06.09.B TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO E..:

Tabatabai, G ; von Baumgarten, L ; van den Bent, M...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii47-ii47 , 2023
Link: https://doi.org/10.1093/..
 
?
8

185P Interim analysis of the EOGBM1-18 study: Strong immune..:

Wick, W. ; Gamelas Magalhaes, J. ; Dos Santos Leite, A.M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100297 , 2022
Link: https://doi.org/10.1016/..
 
?
9

170P EO2401 microbiome derived therapeutic vaccine + nivolu..:

Wick, W. ; IdBaih, A. ; Vieito Villar, M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100282 , 2022
Link: https://doi.org/10.1016/..
 
?
10

P11.15.B First multicentric real-life experience with the c..:

Lazaridis, L ; Schmidt, T ; Agkatsev, S...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii58-ii59 , 2022
Link: https://doi.org/10.1093/..
 
?
11

PO-1160 Chasing a rarity: a retrospective single centre eva..:

Koeksal, M. ; Dejonckheere, C. ; Böhner, A....
Radiotherapy and Oncology.  170 (2022)  - p. S984 , 2022
Link: https://doi.org/10.1016/..
 
?
12

P14.11 Severe treatment-induced myelosuppression is more fr..:

Zeiner, P S ; Filipski, K ; Forster, M...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii39-ii40 , 2021
Link: https://doi.org/10.1093/..
 
?
13

PL03.4.A Factors associated with health-related quality of ..:

Coomans, M ; Dirven, L ; Aaronson, N...
Neuro-Oncology.  23 (2021)  Supplement_2 - p. ii2-ii3 , 2021
Link: https://doi.org/10.1093/..
 
?
14

P14.96 Gliomatosis cerebri imaging pattern: a treatment-ind..:

Divé, I ; Steidl, E ; Wagner, M...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii90-iii91 , 2019
Link: https://doi.org/10.1093/..
 
?
15

OS7.4 Calculating the net clinical benefit in brain tumor c..:

Coomans, M ; Dirven, L ; Bottomley, A...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii14-iii15 , 2019
Link: https://doi.org/10.1093/..
 
1-15